Sildenafil Citrate | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Sildenafil Citrate
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Sildenafil Citrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

73 API Suppliers, 20 USDMF, 21 CEP/COS, 5 JDMF, 18 EU WC, 14 KDMF, 30 NDC API, 48 Listed Suppliers, $ API Reference Price

73 API Suppliers
20 USDMF
21 CEP/COS
5 JDMF
18 EU WC
14 KDMF
30 NDC API
48 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

36 Drugs in Development

36 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

563 FDF Dossiers, 101 FDA Orange Book, 181 Europe, 52 Canada, 35 Australia, 43 South Africa, 151 Listed Dossiers

563 FDF Dossiers
101 FDA Orange Book
181 Europe
52 Canada
35 Australia
43 South Africa
151 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SUSPENSION;ORAL - EQ 10MG BASE/ML, TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET;ORAL - EQ 20MG BASE

FOR SUSPENSION;ORAL - EQ 10MG BASE/ML
TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 25MG BASE
TABLET;ORAL - EQ 50MG BASE
TABLET;ORAL - EQ 20MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Rochem International Inc, 4 SPI Pharma, 7 DKSH, 2 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 1 Chynops Pharma, 7 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 12 BASF, 1 Bioplus Life Sciences, 1 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 29 Controlled & Modified Release, 22 Thickeners and Stabilizers, 19 Lubricants & Glidants, 17 Film Formers & Plasticizers, 17 Disintegrants & Superdisintegrants, 17 Direct Compression, 15 Granulation, 13 Topical, 11 Taste Masking, 10 Parenteral, 10 Co-Processed Excipients, 7 Rheology Modifiers, 7 Solubilizers, 6 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 5 Empty Capsules, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

54 Fillers, Diluents & Binders
52 Coating Systems & Additives
29 Controlled & Modified Release
22 Thickeners and Stabilizers
19 Lubricants & Glidants
17 Film Formers & Plasticizers
17 Disintegrants & Superdisintegrants
17 Direct Compression
15 Granulation
13 Topical
11 Taste Masking
10 Parenteral
10 Co-Processed Excipients
7 Rheology Modifiers
7 Solubilizers
6 Chewable & Orodispersible Aids
6 API Stability Enhancers
5 Empty Capsules
5 Emulsifying Agents
4 Vegetarian Capsules
4 Coloring Agents
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

225 News #PharmaBuzz

225 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 84 Regulatory FDF Prices, 25 Annual Reports

3 US Medicaid Prescriptions
84 Regulatory FDF Prices
25 Annual Reports

MARKET PLACE

59 APIs, 9 FDF Dossiers

59 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 4 US Exclusivities, 30 Health Canada Patents

5 US Patents
4 US Exclusivities
30 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 11 Others

3 EDQM
2 USP
11 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 58 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

4 All

01 4VIATRIS

filter Product Reset all filters

4 All

01 4SILDENAFIL CITRATE

filter Exclusivity Expiration Date Reset all filters

4 All

01 32026-01-31

02 12030-01-31

filter Exclusivity Code Reset all filters

4 All

01 3M-287

02 1ODE-469

Atman Sildenafil Citrate

Product Main Page

VIATRIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SILDENAFIL CITRATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-287

Exclusivity Expiration Date

2026-01-31

Application Number

203109

Product Number

1

Exclusivity Details

01

VIATRIS

SILDENAFIL CITRATE

Immuno-Oncology 360

Not Confirmed

VIATRIS

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SILDENAFIL CITRATE

Exclusivity Code : M-287

Exclusivity Expiration Date : 2026-01-31

Application Number : 203109

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

VIATRIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SILDENAFIL CITRATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-287

Exclusivity Expiration Date

2026-01-31

Application Number

22473

Product Number

1

Exclusivity Details

02

VIATRIS

SILDENAFIL CITRATE

Immuno-Oncology 360

Not Confirmed

VIATRIS

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SILDENAFIL CITRATE

Exclusivity Code : M-287

Exclusivity Expiration Date : 2026-01-31

Application Number : 22473

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

VIATRIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SILDENAFIL CITRATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-469

Exclusivity Expiration Date

2030-01-31

Application Number

21845

Product Number

1

Exclusivity Details

03

VIATRIS

SILDENAFIL CITRATE

Immuno-Oncology 360

Not Confirmed

VIATRIS

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SILDENAFIL CITRATE

Exclusivity Code : ODE-469

Exclusivity Expiration Date : 2030-01-31

Application Number : 21845

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

VIATRIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SILDENAFIL CITRATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-287

Exclusivity Expiration Date

2026-01-31

Application Number

21845

Product Number

1

Exclusivity Details

04

VIATRIS

SILDENAFIL CITRATE

Immuno-Oncology 360

Not Confirmed

VIATRIS

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SILDENAFIL CITRATE

Exclusivity Code : M-287

Exclusivity Expiration Date : 2026-01-31

Application Number : 21845

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!